RELAY THERAPEUTICS INC's ticker is RLAY and the CUSIP is 75943R102. A total of 177 filers reported holding RELAY THERAPEUTICS INC in Q4 2023. The put-call ratio across all filers is 3.84 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $752 | -35.2% | 115,278 | -17.7% | 0.00% | – |
| Q1 2024 | $1,161 | -64.2% | 139,996 | -52.5% | 0.00% | -100.0% |
| Q4 2023 | $3,245 | +79.1% | 294,785 | +36.8% | 0.00% | 0.0% |
| Q3 2023 | $1,812 | -53.3% | 215,469 | -30.3% | 0.00% | -50.0% |
| Q2 2023 | $3,882 | +21.2% | 309,179 | +59.0% | 0.00% | +100.0% |
| Q1 2023 | $3,203 | -21.1% | 194,470 | -28.5% | 0.00% | -50.0% |
| Q4 2022 | $4,061 | -99.9% | 271,839 | +81.0% | 0.00% | -50.0% |
| Q3 2022 | $3,361,000 | +187.5% | 150,211 | +115.2% | 0.00% | +300.0% |
| Q2 2022 | $1,169,000 | -48.7% | 69,807 | -8.2% | 0.00% | -50.0% |
| Q1 2022 | $2,277,000 | – | 76,068 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Casdin Capital, LLC | 5,998,574 | $75,342,089 | 6.58% |
| Nextech Invest Ltd. | 948,659 | $11,915,157 | 4.05% |
| MPM BioImpact LLC | 1,354,368 | $17,010,862 | 3.42% |
| Finepoint Capital LP | 701,570 | $8,811,719 | 3.05% |
| SB INVESTMENT ADVISERS (UK) LTD | 27,904,963 | $350,486,335 | 2.67% |
| EcoR1 Capital, LLC | 4,163,824 | $52,297,629 | 1.28% |
| BVF INC/IL | 3,120,521 | $39,193,744 | 1.09% |
| Integral Health Asset Management, LLC | 700,000 | $8,792,000 | 1.09% |
| Boxer Capital, LLC | 1,819,132 | $22,848 | 1.06% |
| Alphabet Inc. | 1,568,753 | $19,703,537 | 1.06% |